19-11243278-CAGTT-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_020812.4(DOCK6):c.1362_1365delAACT(p.Thr455fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000485 in 1,609,650 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000044 ( 0 hom. )
Consequence
DOCK6
NM_020812.4 frameshift
NM_020812.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.43
Genes affected
DOCK6 (HGNC:19189): (dedicator of cytokinesis 6) This gene encodes a member of the dedicator of cytokinesis (DOCK) family of atypical guanine nucleotide exchange factors. Guanine nucleotide exchange factors interact with small GTPases and are components of intracellular signaling networks. The encoded protein is a group C DOCK protein and plays a role in actin cytoskeletal reorganization by activating the Rho GTPases Cdc42 and Rac1. Mutations in this gene are associated with Adams-Oliver syndrome 2. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-11243278-CAGTT-C is Pathogenic according to our data. Variant chr19-11243278-CAGTT-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 183335.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr19-11243278-CAGTT-C is described in Lovd as [Likely_pathogenic]. Variant chr19-11243278-CAGTT-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOCK6 | NM_020812.4 | c.1362_1365delAACT | p.Thr455fs | frameshift_variant | 12/48 | ENST00000294618.12 | NP_065863.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOCK6 | ENST00000294618.12 | c.1362_1365delAACT | p.Thr455fs | frameshift_variant | 12/48 | 1 | NM_020812.4 | ENSP00000294618.6 | ||
DOCK6 | ENST00000587656.6 | c.1362_1365delAACT | p.Thr455fs | frameshift_variant | 12/49 | 5 | ENSP00000468638.2 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152212Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
14
AN:
152212
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000376 AC: 9AN: 239156Hom.: 0 AF XY: 0.0000307 AC XY: 4AN XY: 130198
GnomAD3 exomes
AF:
AC:
9
AN:
239156
Hom.:
AF XY:
AC XY:
4
AN XY:
130198
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000439 AC: 64AN: 1457438Hom.: 0 AF XY: 0.0000497 AC XY: 36AN XY: 724688
GnomAD4 exome
AF:
AC:
64
AN:
1457438
Hom.:
AF XY:
AC XY:
36
AN XY:
724688
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74370
GnomAD4 genome
AF:
AC:
14
AN:
152212
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Adams-Oliver syndrome 2 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 12, 2011 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Apr 04, 2024 | - - |
Adams-Oliver syndrome Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Dec 01, 2014 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at